Literature DB >> 874517

HLA-DW2, viral immunity and family studies in multiple sclerosis.

G J Stewart, A Basten, J Guinan, H V Bashir, J Cameron, J G McLeod.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 874517     DOI： 10.1016/0022-510x(77)90231-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  8 in total

1.  The presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosis.

Authors:  J M Greer; M P Pender
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Genetic segregation of multiple sclerosis and histocompatibility (HLA) haplotypes.

Authors:  M Alter; J Quevedo
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

3.  Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis.

Authors:  A Marcadet; C Massart; G Semana; R Fauchet; O Sabouraud; M Merienne; J Dausset; D Cohen
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

4.  HLA-linked and unlinked determinants of multiple sclerosis.

Authors:  H Z Ho; J L Tiwari; R W Haile; P I Terasaki; N E Morton
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Family studies in multiple sclerosis: HLA haplotypes of affected sib-pairs.

Authors:  H J Mayer-Rienecker; S Wegener; B Hitzschke
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

6.  HLA and disease: predictions for HLA haplotype sharing in families.

Authors:  L R Weitkamp
Journal:  Am J Hum Genet       Date:  1981-09       Impact factor: 11.025

7.  Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.

Authors:  S Haahr; A Møller-Larsen; E Pedersen
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

8.  Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones.

Authors:  S Jacobson; G T Nepom; J R Richert; W E Biddison; H F McFarland
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.